1 in 3 with lupus takes supplements, medications with potential for interactions

Nearly 1 in 3 patients with systemic lupus erythematosus (SLE) are taking a supplement-medication combination with potential for an interaction, according to a study published online Sept. 22 in Arthritis Care & Research.

≈